EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with tralokinumab

Jill I. Olydam; Linde E.M. de Wijs; Willem A. Dik; Mads A. Røpke; Joel Correa Da Rosa; Dirk Jan Hijnen

doi:10.1016/j.jid.2022.06.008

EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with tralokinumab

Jill I. Olydam
, Linde E.M. de Wijs
, Willem A. Dik
, Mads A. Røpke
, Joel Correa Da Rosa
, Dirk Jan Hijnen^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

90 Downloads (Pure)

Original language	English
Pages (from-to)	3335-3337.e1
Number of pages	2
Journal	Journal of Investigative Dermatology
Volume	142
Issue number	12
Early online date	14 Jul 2022
DOIs	https://doi.org/10.1016/j.jid.2022.06.008
Publication status	Published - Dec 2022
Event	4th Inflammatory Skin Disease Summit - New York Duration: 3 Nov 2021 → 6 Nov 2021

Bibliographical note

Funding Information:
The authors wish to thank Athula Herath for his helpful contributions to the statistical analysis of this manuscript. The study was performed in Rotterdam, The Netherlands. The study was supported by LEO Pharma A/S .

Access to Document

10.1016/j.jid.2022.06.008Licence: CC BY-NC-ND

EASI p-EASI Predicting Disease Severity in Patients with Atopic Dermatitis Treated with TralokinumabFinal published version, 398 KBLicence: CC BY-NC-ND

Cite this

@article{4cba0b006ddc4f93965401f7313dda22,

title = "EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with tralokinumab",

author = "Olydam, \{Jill I.\} and \{de Wijs\}, \{Linde E.M.\} and Dik, \{Willem A.\} and R{\o}pke, \{Mads A.\} and \{Da Rosa\}, \{Joel Correa\} and Hijnen, \{Dirk Jan\}",

note = "Funding Information: The authors wish to thank Athula Herath for his helpful contributions to the statistical analysis of this manuscript. The study was performed in Rotterdam, The Netherlands. The study was supported by LEO Pharma A/S . ; 4th Inflammatory Skin Disease Summit ; Conference date: 03-11-2021 Through 06-11-2021",

year = "2022",

month = dec,

doi = "10.1016/j.jid.2022.06.008",

language = "English",

volume = "142",

pages = "3335--3337.e1",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - EASI p-EASI

T2 - 4th Inflammatory Skin Disease Summit

AU - Olydam, Jill I.

AU - de Wijs, Linde E.M.

AU - Dik, Willem A.

AU - Røpke, Mads A.

AU - Da Rosa, Joel Correa

AU - Hijnen, Dirk Jan

N1 - Funding Information: The authors wish to thank Athula Herath for his helpful contributions to the statistical analysis of this manuscript. The study was performed in Rotterdam, The Netherlands. The study was supported by LEO Pharma A/S .

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85136592801

U2 - 10.1016/j.jid.2022.06.008

DO - 10.1016/j.jid.2022.06.008

M3 - Article

C2 - 35843313

AN - SCOPUS:85136592801

SN - 0022-202X

VL - 142

SP - 3335-3337.e1

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 12

Y2 - 3 November 2021 through 6 November 2021

ER -

EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with tralokinumab

Bibliographical note

Access to Document

Other files and links

Cite this